Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer Pharmaceutical Investing
European Commission Approves Merck’s KEYTRUDA (pembrolizumab) in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC Pharmaceutical Investing
Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing Pharmaceutical Investing
Harvest One to Supply the Ontario Cannabis Store with High-Quality Cannabis for the Adult Use Market Cannabis Investing News
Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101 Biotech Investing
Atara Biotherapeutics and Moffitt Cancer Center Announce Strategic Collaboration to Develop Next-Generation CAR T Immunotherapies Biotech Investing
Verona Pharma Announces Publication of Key Paper on RPL554 in COPD in the European Respiratory Journal Pharmaceutical Investing
